Investors

Latest Financial Results

Q2 2016

Quarterly Results

Ended Apr 30, 2016

Stock Data

NASDAQ ITUS
Price
Change
Volume
Day Range
52 Wk Range

Company Overview

ITUS Corporation funds, develops, acquires and licenses emerging technologies in areas such as biotechnology. The Company’s primary focus is Cchek™, a platform for non-invasive blood tests for the early detection of solid tumor based cancers.